S
Scribeable
Pricing
Sign In
Home/Clinical calculators/PI-RADS (Prostate Imaging Reporting and Data System)

Clinical calculator · Urology

PI-RADS (Prostate Imaging Reporting and Data System)

Standardizes prostate MRI interpretation to guide biopsy decisions for clinically significant prostate cancer detection

Highest activation tier
Recommended
How it is scored
Scored in code; a detected disagreeing draft value is flagged for correction
Scoring type
classification
Care settings
Inpatient, Outpatient

When it activates

Scribeable activates a calculator from the encounter. The PI-RADS (Prostate Imaging Reporting and Data System) can activate when the transcript or pasted chart context documents any of these:

  • Prostate MRI interpretation
  • Prostate lesion characterization
  • Prostate biopsy decision
  • Elevated PSA workup
  • Prostate cancer risk assessment

A coded diagnosis can also activate it. ICD-10 prefixes carried by the registry: C61, N40, R97.20.

  • BPH N40.0
  • Prostate Ca C61

Inputs the note needs

1 input. Each is resolved from the transcript, the pasted chart context and charted labs; at this calculator’s tier a missing input is never requested, and a missing required input keeps the score out of the draft.

InputTypeUnit / optionsGuidance
PI-RADS assessment category (1-5)exam

Reference for licensed clinicians. Where the registry text carries dose thresholds or conversion factors, they are as published in the cited sources. This page is not a prescribing tool and not individualised medical advice; verify against a current drug reference and the current guideline before acting. Medical disclaimer.

Scoring

PI-RADS 1: Very low (clinically significant cancer highly unlikely). PI-RADS 2: Low (clinically significant cancer unlikely). PI-RADS 3: Intermediate (equivocal — clinically significant cancer presence is equivocal). PI-RADS 4: High (clinically significant cancer likely). PI-RADS 5: Very high (clinically significant cancer highly likely). Based on T2-weighted, DWI/ADC, and DCE sequences with zone-specific scoring (peripheral vs transition zone).

Interpretation

PI-RADS 1-2: Biopsy generally not recommended on imaging alone. PI-RADS 3: Clinical factors determine biopsy decision (PSA density >0.15, strong family history, prior suspicious biopsy favor biopsy). PI-RADS 4-5: MRI-targeted biopsy recommended (fusion or cognitive targeting). Clinically significant cancer detection rates: PI-RADS 3 ~16%, PI-RADS 4 ~40-50%, PI-RADS 5 ~70-85%. Combined with PSA density for optimal risk stratification.

Evidence

Sources carried in Scribeable's citation registry for this calculator; guideline version: ACR PI-RADS v2.1.

  • Turkbey B et al. Prostate Imaging Reporting and Data System Version 2.1 (PI-RADS v2.1)ACR PI-RADS v2.1 · 2019 · ACR · Consensus · link last verified 2026-03-28

How Scribeable handles it in the note

When an encounter activates the PI-RADS (Prostate Imaging Reporting and Data System) (its highest tier is recommended), Scribeable does not ask you for missing inputs. The score is computed in code from whatever inputs resolve from the transcript, the pasted chart context or charted labs; a computed value is written into the draft only when every required input already resolves.

The score is computed in code from the resolved inputs, not recalled by the language model. If the draft states a PI-RADS (Prostate Imaging Reporting and Data System) value that disagrees with the computed one, the disagreement is flagged to the second drafting pass, which is instructed to correct the score and its interpretation before you see the note.

Classified as a staging or classification system: activated strictly, because a wrong stage on the wrong patient is a documentation hazard.

Related calculators

  • Gleason Score / ISUP Grade GroupGrades prostate cancer aggressiveness to guide treatment decisions and prognosis
  • International Prostate Symptom Score (IPSS)Quantifies lower urinary tract symptom severity from BPH to guide treatment selection and monitor response
  • BI-RADS (Breast Imaging Reporting and Data System)Standardizes breast imaging assessment and management recommendations to ensure consistent reporting and follow-up
  • Fleischner Society Criteria for Pulmonary Nodule Follow-upProvides evidence-based follow-up recommendations for incidental pulmonary nodules based on size, type, and patient risk factors
  • Fuhrman/WHO-ISUP Nuclear Grade for Renal Cell CarcinomaGrades nuclear atypia in clear cell RCC to predict prognosis and guide surveillance intensity
  • LI-RADS (Liver Imaging Reporting and Data System)Standardizes liver imaging interpretation for hepatocellular carcinoma diagnosis in at-risk patients

Can activate in: Urology, Oncology, Hematology, Radiology & Interventional Radiology.

Scored in code

See it activate on your own encounter

14 days of full Pro. No sales call.

Start free trialHow calculator scoring works

14-day Pro trial, no credit card required. Everything in Pro, including Rounding, for up to 150 notes. To keep Pro after day 14, subscribe for $79/month plus applicable tax. If you don't, nothing is charged and your account becomes read-only, with every note kept.

S
Scribeable

Clinician-owned software for the doctor who still wants to be a doctor. Portable across every job you’ll ever have.

Product

  • Features
  • Pricing
  • Rounding Mode
  • Founding Physician
  • Group Practices
  • Health Systems & Hospitals

Company

  • About
  • Trust & Compliance
  • Security
  • Blog
  • Contact

Compare

  • vs Dragon Copilot
  • vs Abridge
  • vs Heidi
  • Alternatives
  • All Comparisons

Resources

  • Documentation
  • Support
  • Specialties
  • Calculator Registry
  • Status

Legal

  • Privacy
  • Terms
  • BAA
  • Legal Hub
All pages →

Product

  • Features
  • Pricing
  • Rounding Mode
  • Founding Physician
  • Security
  • Documentation
  • EHR Integrations
  • Solutions

Who it's for

  • Primary Care
  • Psychiatry
  • Hospitalist Groups
  • Emergency Medicine
  • Concierge & DPC
  • Solo Providers
  • Residents & Students
  • Group Practices
  • Telehealth
  • Health Systems & Hospitals

Capabilities

  • Rounding Mode
  • Referral Letters
  • Clinical Calculators
  • After Visit Summaries
  • Document Generation
  • Quality Reporting
  • HCC Coding
  • Template Marketplace

Specialties

  • Internal Medicine
  • Primary Care
  • Emergency Medicine
  • Psychiatry
  • Surgery
  • Pediatrics
  • Cardiology
  • Urgent Care
  • All Specialties

Compare

  • vs Dragon Copilot
  • vs Nabla
  • vs Abridge
  • vs DeepScribe
  • vs Suki
  • vs Heidi
  • Note Quality
  • Alternatives
  • All Comparisons

Guides

  • AI Scribe Pricing
  • Best AI Scribe 2027
  • Ambient Documentation Guide
  • AI Scribe for Doctors
  • Pricing Transparency Index
  • ROI Calculator

Company

  • About
  • Our Mission
  • The Scribeable Method
  • Trust & Compliance
  • Transparency
  • Case Studies
  • Reviews
  • Scribeable EMR (concept)
  • Contact

Resources

  • Support
  • FAQ
  • Blog
  • Clinical Calculator Registry
  • Conditions
  • Procedures
  • Locations by State
  • Status

Legal

  • Privacy
  • Terms
  • BAA
  • DPA
  • Medical Disclaimer
  • Legal Hub

HIPAA

Safeguards

SOC 2 readiness

In progress, no report yet

BAA

Every plan, and the trial

AES-256

Encryption

MEDICAL DISCLAIMER: Scribeable is a documentation tool, not a medical device. All AI-generated content must be reviewed and approved by licensed healthcare providers before use in patient care. Scribeable does not provide medical advice, diagnosis, or treatment recommendations. See full Medical Disclaimer.

© 2026 Scribeable LLC All rights reserved.

US-Based Servers·GDPR and CCPA rights: see our Privacy Policy·Your Privacy Choices·